Bilal Ersen Kerman

Assistant Professor of Research Medicine

Image of Bilal Ersen Kerman
Is this your profile? Click to edit

Publications

  • CNS target engagement of high-dose DHA supplementation in older adults at risk for dementia: a randomised, double-blind, placebo-controlled trial. EBioMedicine. 2026 Jul; 129:106316.. View in PubMed
  • A perspective: PLA2G4A as drug target for vascular inflammation in Alzheimer’s disease. Alzheimers Dement. 2026 Apr; 22(4):e71320.. View in PubMed
  • Evidence for cPLA2 activation in Alzheimer’s disease synaptic pathology. Acta Neuropathol Commun. 2026 02 12; 14(1).. View in PubMed
  • Development of potent, selective cPLA2 inhibitors for targeting neuroinflammation in Alzheimer’s disease and other neurodegenerative disorders. NPJ Drug Discov. 2026; 3(1):2.. View in PubMed
  • Microglial States Are Susceptible to Senescence and Cholesterol Dysregulation in Alzheimer’s Disease. Aging Cell. 2025 10; 24(10):e70189.. View in PubMed
  • Increased cerebrospinal fluid and plasma apoE glycosylation is associated with reduced levels of Alzheimer’s disease biomarkers. Alzheimers Res Ther. 2025 07 10; 17(1):151.. View in PubMed
  • Evidence for cPLA2 activation in Alzheimer’s Disease Synaptic Pathology. bioRxiv. 2025 Apr 01.. View in PubMed
  • Cellular senescence induced by cholesterol accumulation is mediated by lysosomal ABCA1 in APOE4 and AD. Mol Neurodegener. 2025 Feb 04; 20(1):15.. View in PubMed
  • Increased cerebrospinal fluid and plasma apoE glycosylation is associated with reduced levels of Alzheimer’s disease biomarkers. bioRxiv. 2024 Dec 21.. View in PubMed
  • Microglia States are Susceptible to Senescence and Cholesterol Dysregulation in Alzheimer’s Disease. bioRxiv. 2024 Nov 18.. View in PubMed